| Sandy K Evans, RN | |
|
1 Hospital Rd, Belcourt, ND 58316-0160 | |
| (701) 477-6111 | |
| Not Available |
| Full Name | Sandy K Evans |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1 Hospital Rd, Belcourt, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669656583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 041-28806 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandy K Evans, RN Po Box 160, Belcourt, ND 58316-0160 Ph: (701) 477-6111 | Sandy K Evans, RN 1 Hospital Rd, Belcourt, ND 58316-0160 Ph: (701) 477-6111 |
News Archive
Mary Agnes Carey writes about what might become of the Children's Health Insurance Program. One of it's staunchest backers, Sen. Jay Rockefeller, D- W.Va., isn't ready to see it swallowed up by a new health insurance marketplace designed by Congress (Kaiser Health News).
Moffitt Cancer Center researchers have identified a gene that may better predict survival for pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States.
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
A meta-analysis shows that clinical worsening is significantly less likely in patients with pulmonary arterial hypertension if they are given combination treatment, rather than monotherapy.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 9 days ago
Ms. Kristina F Davis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 | |
Aleta Jean Peltier, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 | |
Shannon L Lunday, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8410 | |
Nicole L Lenoir, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 | |
Angela Ann Keplin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8410 | |
Crystal V Martin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 | |
Margaret M Pederson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 |